Tuesday’s Runners, 3 Possible Trades

Notable Movers from Tuesday:

We didn’t sweep the entire board on Tuesday, with only two of the three options ideas we were tracking yielding positive result. Still, two out of three isn’t half-bad, and the targets from our premarket report that did run, ran pretty hard. There were four contract sets, and they all cracked into double bag territory.

Those ideas were the UNFI Weekly $33-34 Calls, and the LW 10/17 $57.50-60 Calls. They recorded the following upswings on the day:

UNFI Weekly $33-34 Calls
$33: 
2.39-5.17 (+116%)
$34: 2.15-4.40 (+105%)
_____

LW 10/17 $57.50-60 Calls
$57.50: 1.70-3.60 (+112%)
$60: .73-2.18 (+199%)


Fresh Options Ideas:
NKE Weekly $72-73 Calls
RPM 10/17 $115 Puts
CALM 10/17 $85 Puts


Extended Watchlist:
CJET, BURU, RVYL, LAC, RZLV, MASK, CAPS

Options Recaps, Trio of Fresh Plays

Back in the Saddle:

Welcome back, traders! Our summer vacation is over, and we’re ready to hit the ground running. We hope everyone had a constructive trading week in our absence. Although now a full week in the rear view, we’ll go ahead and report on the performances of our trading ideas in our last premarket report on Friday the 15th, and then jump forward to some new targets for today.

We had the AMAT Weekly $167.50-165 Puts, the SNDK Weekly $45 Puts, and the GLOB Weekly $70-65 Puts in the report that morning, and here was how they ultimately played out:

AMAT Weekly $167.50-165 Puts
$167.50:
 1.69-5.93 (+251%)
$165: .60-3.30 (+450%)
_____

SNDK Weekly $45 Puts
$45:
 .15-1.19 (+693%)
_____

GLOB Weekly $70-65 Puts
$70: 1.50-5.30 (+253%)
$65: .10-.89 (+790%)


Fresh Options Ideas:
PDD Weekly $128-127 Puts
RH Weekly $227.50-225 Puts
PEG 09/19 $82.50-85 Calls


Extended Watchlist:
OPEN, EPIX, OSRH, CAPS, HCWB, STSS, OPAD, ASST, QIPT, JFU, MRM

Blue Horseshoe Stocks: Pharma News Watchlist & More

Pharma News Watchlist:

We’ve got a trio of pharma plays to add to our watchlist on the heels of fresh news releases for each of them this morning. Each stock is gapping up significantly in the premarket, and we’ll be waiting in the wings once the session commences to see if we can use the resulting activity to our advantage.

Akebia Therapeutics, Inc. AKBA – Per the newly announced agreement out today, AKBA has entered into a Collaboration and License Agreement to carry forward with the development of one of its treatments. The deal comes with an immediate payment of $125M, a cash infusion that represents roughly 40% of the company’s total market cap as of yesterday.

______

ACADIA Pharmaceuticals, Inc. ACAD – In the case of ACAD, we’ve gotten word of positive top-line results in a Phase II study it was conducting on the company’s Alzheimer’s drug.  To leverage the present activity to our advantage here, we’re going to track the ACAD Weekly $28-31 Calls. (>>View PR)

_______

Conatus Pharmaceuticals, Inc. CNAT

Here we have another collaboration and licensing deal, for CNAT’s liver drug, which is going to be bringing a $50M cash infusion Conatus’ way. That’s just the initial tranche, with more payments to follow as outlined in the relevant filing (>>View 8-K)


Globalstar, Inc. GSAT

We put GSAT on watch as a possible momentum play in yesterday morning’s premarket report, and while it didn’t break out in a major way, it did continue the trend of solid upward momentum that has been observed in recent sessions. From an early low of 1.25, the stock ran as high as 1.60; a 28% pop.

The performance, while not astronomical, was certainly enough to hold our interest in continuing to monitor GSAT’s activity moving forward.


Cellectar Biosciences, Inc. CLRB – Reminder

We just wanted to take a quick moment to reiterate a possible bottom-play selection we made last week in the form of CLRB. We’re still tracking this one, and think it has a good chance to produce a recovery, possibly following the holiday break. So we’re going to want to leave a space on our watch screens reserved for CLRB in the days and weeks ahead.


Extended Watchlist:
AXPW, CAPS, MFST, ENDV, ETRM, EXAD

Get Our FREE Daily Reports!